In the midst of the growing infection of the epidemic, there is also increasing hope about medicine. The first part of Phase-I of human trials of covaxin was completed at PGI Rohtak. After the vaccine test, the team's chief investigator, Dr. Savita Verma has given this information. Talking to the media, he told that 6 people have been vaccinated in the second phase of Phase-1 on Saturday.

He said, 'The first part of the first phase of human trials of covaxin has been completed. 50 people have been given medicine in India. The results are encouraging. On Saturday, six people were vaccinated during the second part of the trial.

Let us tell you that covaxin is India's first vaccine, which was allowed to be tested. Its investigation was started on 17 July in PGI Rohtak. On this day 3 people were given the vaccine. In Delhi AIIMS also, the first phase of clinical trial on 'Kovaxin' humans started on Friday (July 24). The first injection was given to a person between 30 and 40 years of age. More than 3,500 people have registered themselves for testing at AIIMS since last Saturday (18 July), out of which at least 22 screenings have started. This information has been received from Dr. Sanjay, Professor and Chief Studies, Community Medicine Center at AIIMS. It seems from the news received from him that the drug of Corona may soon be displayed in the Indian market.

Also Read:

WHO warns, 'Corona breaking records across the world'

Uddhav Thackeray attacks BJP, says' What are you waiting for, topple my government now'

Hurricane continues to wreak havoc in Texas, major devastation may occur

First case of corona found in North Korea, emergency declared